Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Dame Molly Stevens

Professor Dame Molly Stevens

Molly Stevens

FREng FRS


John Black Professor of Bionanoscience - Department of Physiology, Anatomy and Genetics and Institute of Biomedical Engineering

Professor Stevens joined the PSI in 2024, where she co-leads the diagnostics theme while also contributing to the development of next-generation vaccine formulations.

Professor Stevens’ multidisciplinary research balances the investigation of fundamental science with the development of technologies and designer biomaterials to address some of the major healthcare challenges across diagnostics, advanced therapeutics and regenerative medicine. Her research influences scientists around the world (>430 publications, h-index 121, >55k citations, consistently recognized as a Clarivate Highly Cited Researcher in the cross-field category for multiple years, including 2024). The impact of her work is recognised by over 30 accolades, including the 2023 Novo Nordisk Prize.

Professor Stevens’ work has a strong translational drive, focussed on translating scientific innovation into practical solutions to benefit patients and society. She is a serial entrepreneur and the founder of several spin-off companies in the diagnostics, advanced therapeutics, and regenerative medicine space.